Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients

Laboratory Investigation

Volumn 82, Issue 3, 2002, Pages 257-264

  Hoshida, Yoshihiko ^a   Hongyo, Tadashi ^a   Nakatsuka, Shin Ichi ^a   Nishiu, Mieko ^a   Takakuwa, Tetsuya ^a   Tomita, Yasuhiko ^a   Nomura, Taisei ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MYC PROTEIN; PROTEIN P53; STEM CELL FACTOR;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CLINICAL ARTICLE; CPG ISLAND; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; ONCOGENE C MYC; ONCOGENE K RAS; ONCOGENE N RAS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0036129062     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780419     Document Type: Article

References (39)

1. β-catenin is a target for the ubiquitin-proteosome pathway
2. p53 mutation and expression in lymphoma
3. K-ras mutation in human carcinoma after kidney transplantation
4. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma
5. Ras gene
6. Functional interactions of β-catenin with the transcription factor LEF-1
7. Microsatellite instabilitiy and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis
8. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant
9. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients
10. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
11. Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphoma
12. β-catenin mutation in carcinoma of the uterine endometrium
13. Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis
14. Posttransplant lymphoproliferative disorders: Summary of society for hematopathology workshop
15. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
16. Identification of c-myc as a target of the APC pathway
17. p53 mutations in human cancers
18. 'Cold SSCP': A simple, rapid and non-radioactive method for optimized single strand conformation polymorphism analyses
19. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan
20. Lymphoproliferative disorders in renal transplant patients in Japan
21. β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
22. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics
23. Cadherins and catenins in development
24. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma
25. p53 in hematologic malignancies
26. Stimulated human leukocytes cause activating mutations in the K-ras protooncogene
27. Neoplastic trasformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase
28. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
29. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center
30. The p53 tumor suppressor gene
31. Mutations of the p53 gene in nasal NK/T-cell lymphoma
32. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
33. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
34. Analysis of ras oncogene mutations in human lymphoid malignancies
35. Malignant lymphoma in transplantation patients
36. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
37. Reversibility of tymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy
38. Microsatellite instability and K-ras, p53 mutations in thyroid lymphoma
39. β-catenin mutations in human prostate cancer